Dejian Zhou

We are developing polyvalent multifunctional nanoparticles (PMNs) to maximize the activity and accessibility of conjugated biomolecules and fully exploit multivalency to enhance targeting affinity and specificity. Our PMNs can be tailored for applications such as targeting antigen presenting cells to modulate their immune responses for potential immunotherapeutic treatment for allergy, cancer, and diabetes. They can also act as anti-viral and anti-bacterial agents.